RELATIONSHIP BETWEEN SERUM LEVELS OF IMMUNOGLOBULIN M-ANTI PHENOLIC GLYCOLIPID 1 AND IMMUNOGLOBULIN G-ANTI PHENOLIC GLYCOLIPID 1 WITH BACTERIA INDEX VALUES IN MULTIBACILLARY LEPROSY

Authors

  • FITRIYANTI FITRIYANTI Department of Skin and Venereology Raden Mattaher Hospital/Faculty of Medicine, University of Jambi, Indonesia.

DOI:

https://doi.org/10.22159/ajpcr.2021.v14i10.42565

Keywords:

Immunoglobulin M-anti-phenolic glycolipid 1, Immunoglobulin G-anti-phenolic glycolipid, Bacterial index, Slit skin smear

Abstract

Objective: This study aims to determine the relationship of serum levels of anti-phenolic glycolipid (PGL-1), immunoglobulin M (IgM), and anti-PGL-1 immunoglobulin G (IgG) with bacterial index (BI) values in multibacillary (MB) leprosy.

Methods: This study was an observational study with a cross-sectional design. A total of 30 study samples were examined for a Slit Skin Smear and examined serum levels of IgM and IgG Anti PGL-1 antibodies by ELISA method.

Results: The results showed the higher the BI value, the serum levels of IgM anti-PGL-1 and IgG anti-PGL-1 increased.

Conclusion: There was a significant relationship between IgM anti-PGL-1 with BI value in MB leprosy (p<0.05), but there was no significant relationship between IgG anti-PGL-1 with BI value in MB leprosy (p>0.05). IgM anti-PGL-1 has more role in increasing the value of BI in MB leprosy.

Downloads

Download data is not yet available.

References

Wang H, Liu W, Jin Y, Yu M, Jiang H, Tamura T, et al. Detection of antibodies to both M. Leprae PGL-1 and MMP-II to recognize leprosy patients at an early stage of disease progression. Diagn Microbiol Infect Dis 2015;83:274-7.

Brito P, Junior JE, de Macedo AC, Alves AR, Goncalves TB, Brito T, et al. Anti-PGL 1 salivary IgA/IgM, serum IgG/IgM, and nasal mycobacterium leprae DNA in individuals with household contact with leprosy. Int J Infect Dis 2013;17:e1005-10.

Eichelman K, Gonzalez SE, Salas-Alanis JC, Ocampo-Candiani J. Leprosy. An update: Definition, pathogenesis, classification, diagnosis,and treatment. Actas Dermosifiliogr 2013;104:554-63.

Paredes Carlos F, Morales A. Unsolved matters in Leprosy: A descriptive review and call for further research. Ann Clin Microbiol Antimicrob 2016;15:33.

Garbin CA, Garbin AJ, Carloni ME, Rovida TA, Martin RJ. The stigma and prejudice of leprosy: Influence on the human condition. Rev Soc Bras Med Trop 2015;48:194-201.

Kemenkes RI. Menkes Canangkan Resolusi Jakarta Guna Hilangkan Stigma dan Diskriminasi Kusta; 2018. p. 1-3. Available from: http:// www.depkes.go.id. [Last accessed on 2018 Sep].

Kemenkes RI. Profil Kesehatan Indonesia Tahun 2015. Jakarta: Kemenkes RI; 2016. p. 175-8.

Dinas Kesehatan Provinsi Jambi. Profil Kesehatan Provinsi Jambi Tahun 2014. Jambi: Dinkesprov Jambi; 2015. p. 53-6.

Silva R, Sekula SB, Penna ML, Penna GO, Talhari S. Leprosy: Current situation, clinical and laboratory aspects, treatment history and perspective of the uniform multidrug therapy for all patients. An Bras Dermatol 2017;92:761-73.

Nobre ML, Illarramendi X, Kathryn MD, Hacker MA, Nery JA, Jeronimo SM, et al. Multibacillary leprosy by population groups in Brazil: Lessons from an observational study. PLoS Negl Trop Dis 2017;11:e0005364.

Reibel F, Cambau E, Aubry A. Update on the epidemiology, diagnosis and treatment of leprosy. Med Mal Infect 2015;45:383-93.

Mahajan VK. Slit-skin smear in leprosy: Lest we forget it! Indian J Lepr 2013;85:177-83.

Hamzah MS. Hubungan Transforming Growth Factor-β Dengan Eritema Nodosum Leprosum Berulang Berdasarkan Immunoglobulin-M Anti Phenolic-Glycolipid-1 dan Kortisol (Tesis Magister). Padang: Pascasarjana Universitas Andalas; 2016.

Srihartati E, Agusni I. Uji serologik anti PGL-1 pada penderita kusta. Surabaya 2010;22:165-71.

Retnowati E, Wijaya H, Agusni I. Total IgG and IgG anti PGL-1 with duration of theraphy. Indones J Clin Pathol Med Lab 2016;2:268-73.

Schuring RP, Moet FJ, Pahan D, Richards JH, Richardus JH, Oskam L. Association between anti-PGL-I and clinical and demographic parameters in leprosy. Lepr Rev 2006;77:343-55.

Price VG. Factors preventing early case detection for women affected by leprosy: A review of the literature. Glob Health Action 2017;10:1360550.

Martin R, Carloni M, Moimaz S, Garbin C. Sociodemographic and epidemiological profile of leprosy patients in an endemic region in Brazil. Rev Soc Bras Med Trop 2016;46:777-80.

Arbues A, Lugo-Villarino G, Neyrolles O, Guilhot C, Astarie-Dequeker C. Playing hide-and-seek with host macrophages through the use of mycobacterial cell envelope phthiocerol dimycocerosates and phenolic glycolipids. Front Cell Infect Microbiol 2014;4:1731-7.

Barreto JG, de Souza Guimarães L, Leão MR, Ferreira DV, Lima RA, Salgado CG. Anti-PGL-1 seroepidemiology in leprosy cases: Household contacts and school children from a hyperendemic municipality of the Brazilian Amazon. Lepr Rev 2011;82:385-90.

Moura RS, Calado KL, Olivveira ML, Skula SB. Leprosy serologi using PGL-I: A systemic review. Rev Soc Bras Med Trop 2008;41:11-8.

Rawlinson WD, Basten A, Hargrave JC. Clinical significance of changes in serum proteins, immunoglobulins, and autoantibodies in leprosy. Int J Lepr Other Mycobact Dis 1987;55:277-85.

Indrayati ES, Utama YU. Gambaran IgG dan IgM anti phenolic glycolipid-1 mycobacterium leprae pada siswa pesantren desa wringin jajar kecamatan mranggen kabupaten demak. Med Med Indones 2009;43:220-3.

Published

07-10-2021

How to Cite

FITRIYANTI, F. “RELATIONSHIP BETWEEN SERUM LEVELS OF IMMUNOGLOBULIN M-ANTI PHENOLIC GLYCOLIPID 1 AND IMMUNOGLOBULIN G-ANTI PHENOLIC GLYCOLIPID 1 WITH BACTERIA INDEX VALUES IN MULTIBACILLARY LEPROSY”. Asian Journal of Pharmaceutical and Clinical Research, vol. 14, no. 10, Oct. 2021, pp. 76-79, doi:10.22159/ajpcr.2021.v14i10.42565.

Issue

Section

Original Article(s)